Soru

Zorluk: OrtaNormal Pregnancy and Prenatal Care

A 25-year-old primigravida presents to the obstetric clinic at 8 weeks gestation for her initial prenatal visit. She has no significant past medical history, takes no medications other than a daily prenatal vitamin, and her physical examination is unremarkable. She wishes to undergo standard comprehensive prenatal care. Arrange the following routine prenatal screening tests and evaluations in the correct chronological sequence in which they are indicated during a normal pregnancy (from earliest to latest gestational age).

  1. 1Routine serologic screening for HIV, syphilis, and hepatitis B
  2. 2Measurement of nuchal translucency and maternal serum pregnancy-associated plasma protein A (PAPP-A)
  3. 3Comprehensive fetal anatomy ultrasound survey
  4. 4Universal screening for gestational diabetes mellitus using a 1-hour 50-g oral glucose challenge test
  5. 5Universal screening for Group B Streptococcus (GBS) colonization via rectovaginal swab

Cevap

The correct sequence is: Routine serologic screening -> Nuchal translucency measurement -> Fetal anatomy ultrasound -> 1-hour 50-g oral glucose challenge test -> Group B Streptococcus culture.
The correct sequence follows standard guidelines for prenatal care in an uncomplicated pregnancy. Initial infectious disease serologies are obtained at the first visit (typically 8-10 weeks). First-trimester aneuploidy screening, including nuchal translucency, is optimal at 11-14 weeks. A comprehensive anatomical survey via ultrasound is best visualized at 18-22 weeks. As placental lactogen levels rise and induce physiological insulin resistance, universal screening for gestational diabetes is performed at 24-28 weeks. Finally, Group B Streptococcus colonization is assessed at 36-38 weeks to provide a 5-week validity window extending through full term.

Adım Adım Çözüm

1
Identify the screening tests performed at the initial prenatal visit (first trimester).
Routine serologic screening for HIV, syphilis, and hepatitis B is performed at the first visit, typically around 8-10 weeks.
Early identification of maternal infectious diseases allows for timely interventions to prevent vertical transmission.
2
Determine the optimal window for early fetal aneuploidy screening.
Measurement of nuchal translucency and maternal serum PAPP-A is performed between 11 and 14 weeks.
This specific gestational age window provides the highest sensitivity and specificity for the first-trimester combined screen.
3
Determine the timing for the comprehensive fetal structural assessment.
The fetal anatomy ultrasound survey is conducted between 18 and 22 weeks.
At this gestational age, fetal structures are adequately developed and amniotic fluid volume is sufficient for detailed visualization.
4
Identify the standard window for gestational diabetes mellitus (GDM) screening in average-risk patients.
The 1-hour 50-g oral glucose challenge test is administered between 24 and 28 weeks.
Insulin resistance driven by placental hormones (e.g., human placental lactogen) peaks late in the second trimester, making this the optimal time for universal screening.
5
Establish the correct timing for Group B Streptococcus (GBS) screening.
Universal screening for GBS via rectovaginal swab is performed between 36 0/7 and 37 6/7 weeks.
Screening is timed such that the culture results accurately reflect the colonization status at the time of delivery (results are considered valid for 5 weeks).

Anahtar Kavram

Chronological sequencing of routine prenatal screening and prophylactic interventions according to standardized obstetric guidelines.
Bu soruyu puanla